Expect the New Pneumonia Antibiotic, Xenleta, to Be Saved for Rare Occasions

Xenleta (zen-LEH-tah, lefamulin) will be a new antibiotic for community-acquired pneumonia (CAP).

It'll be touted to cover resistant infections...since it works differently than other antibiotics (azithromycin, etc).

Plus it will be promoted to reduce hospital stays...since patients can start with the IV form and finish with oral tabs.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals